TMO Thermo Fisher Scientific Inc Common Stock
$590,94
Prezzo · Ago 18, 2026
Fondamentali al Lug 31, 2026
Intervallo 52 sett.
$435–$644
75% of range
Rating Analisti
BUY
36 analysts
Prezzo Obiettivo
$631
+7% upside
P/E (TTM)
33.3
ROE
13.0%
Margine di Profitto Netto
15.0%
Informazioni su Thermo Fisher Scientific Inc Common Stock Panoramica della società da Wikipedia
Thermo Fisher Scientific è un'azienda statunitense che produce strumenti, materiali e software per l'industria farmaceutica e biotecnologica. Nasce nel 2006 dalla fusione di Thermo Electron e Fisher Scientific; attualmente opera con le divisioni Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services e Patheon. L'azienda fa parte dal 2008 delle aziende Fortune 500, la classifica delle 500 maggiori imprese societarie statunitensi misurate sulla base del loro fatturato; nel 2019 occupava il 124 posto. Nello stesso anno impiegava globalmente circa 70.000 persone.
Leggi di più
Thermo Fisher Scientific è un'azienda statunitense che produce strumenti, materiali e software per l'industria farmaceutica e biotecnologica. Nasce nel 2006 dalla fusione di Thermo Electron e Fisher Scientific; attualmente opera con le divisioni Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services e Patheon.
L'azienda fa parte dal 2008 delle aziende Fortune 500, la classifica delle 500 maggiori imprese societarie statunitensi misurate sulla base del loro fatturato; nel 2019 occupava il 124 posto. Nello stesso anno impiegava globalmente circa 70.000 persone.
Nel marzo 2020 fu annunciata l'acquisizione da parte di Thermo Fisher Scientific della società di biotecnologie tedesco-olandese Qiagen per oltre dieci miliardi di dollari. Precedentemente l'azienda aveva compiuto numerose operazioni di acquisizione e fusione, tra cui la società di test sul DNA Life Technologies, nel 2014 per 13,6 miliardi, e la farmaceutica canadese Patheon, nel 2017 per 7,2 miliardi.
## Acquisizioni
Le due società fusesi assieme, Thermo Electron e Fisher Scientific, hanno acquisito 15 società prima della fusione e altre 56 dal 2006, numero che può essere sottostimato.
Nel 2011 viene acquisita dalla Thermo Fisher Scientific Inc. la Phadia per 2,47 miliardi di Euro.
Nel 2013, dopo una competizione con la Hoffmann-La Roche, Thermo Fisher acquista Life Technologies Corporation per 13,6 miliardi di US$.
Nel 2015 è la volta di Advanced Scientifics per 300 milioni di US$. Sempre nello stesso anno viene acquisita la Alfa Aesar per 405 milioni di US$ dalla Johnson Matthey
Nel 2016, avviene l'acquisizione di Affymetrix per 1,3 miliardi di US$. Lo stesso anno di FEI Company per 4,2 miliardi di US$. Nel novembre viene annunciata l'acquisizione di MTI-GlobalStem.
Nel 2017 è la volta di Finesse Solutions, Inc. In marzo quella di Core Informatics. In agosto Patheon, per 7,2 miliardi di US$.
Nel settembre 2018, Thermo Fisher Scientific annuncia l'accordo con Becton, Dickinson and Company (BD) per la loro divisioner Advanced Bioprocessing.
Nel 2019 viene acquisita la Brammer Bio. Nel giugno viene comprata la HighChem.
Nel marzo 2020 prova ad acquisire la Qiagen per 10,1 miliardi di US$, ma la trattativa non va a buon fine .
Thermo Fisher Scientific (formed in 2006 by the merger of Thermo Electron and Fisher Scientific)
Thermo Fisher Scientific
Fisher Scientific
Scientific Materials Co. (Est 1902)
Scientific Supplies, Ltd (Acq 1925)
Eimer & Amend (Acq 1940)
E. Machlett & Sons (Acq 1957)
Janssen Chimica
Eastman Kodak Company (Organic Chemicals division)
Apogent Technologies Inc. (Acq 2004)
Athena Diagnostics (Acq 2006)
Thermo Electron
Kendro Laboratory Products (Acq 2005)
Rupprecht and Patashnick Co., Inc. (Acq 2005)
NITON LLC (Acq 2005)
InnaPhase Corporation (Acq 2004)
US Counseling Services, Inc. (Acq 2004)
Jouan SA (Acq 2004)
Laboratory Management Systems, Inc. (Acq 2003)
Phadia (Acq 2011)
Life Technologies (Acq 2013)
Invitrogen Corporation (Merged 2008)
NOVEX
Research Genetics, Inc (Acq 1999)
Ethrog Biotechnology
Molecular Probes
Dynal
Panvera
InforMax
BioSource
CellzDirect
Zymed
Caltag Laboratories
Applied Biosystems (Merged 2008)
Advanced Scientifics (Acq 2015)
Alfa Aesar (Acq 2015)
Affymetrix (Acq 2016)
Genetic MicroSystems (Acq 1999)
Neomorphic (Acq 2000)
ParAllele Bioscience
USB Corporation (Acq 2008)
Panomics (Acq 2008)
True Materials (Acq 2000)
eBioscience (Acq 2012)
FEI Company
FEI Company (Merged 1997)
Field Electron and Ion Co. (Est 1971)
Philips Electron Optics
Micrion (Acq 1999)
MTI-GlobalStem (Acq 2016)
Finesse Solutions, Inc. (Acq 2017)
Core Informatics (Acq 2017)
Patheon (Acq 2017)
Agere Pharmaceuticals (Acq 2015)
Gallus Pharmaceuticals (Acq 2014)
Royal DSM NV (Pharmaceutical div, merged 2014)
MOVA (Acq 2004)
Banner Pharmacaps (Acq 2013)
== Marchi posseduti dalla Thermo-Fisher ==
Fonte: Wikipedia, CC BY-SA 4.0 · Vedi su Wikipedia ↗
TMO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$590.93
Capitalizzazione di Mercato
$262.97B
P/E (TTM)
33.3
EPS (TTM)
$17.74
Ricavi (TTM)
$44.56B
Rendimento div.
0.25%
ROE
13.0%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$435 – $644
TMO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$44.56B
2021-12-31
→
2025-12-31
EPS
$17.74
2021-12-31
→
2025-12-31
Flusso di cassa libero
$6.29B
2021-12-31
→
2025-12-31
Margini
15.0%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
TMO
Mediana dei peer
P/E (TTM)
33.3
17.5
P/S (TTM)
5.9
3.3
P/B
4.9
2.1
Price / FCF (Prezzo / FCF)
41.8
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
TMO
Mediana dei peer
Operating Margin (Margine Operativo)
17.4%
—
Net Profit Margin (Margine di Profitto Netto)
15.0%
-56.5%
ROA
6.5%
-17.2%
ROE
13.0%
-41.3%
ROIC
13.4%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
TMO
Mediana dei peer
Current Ratio (Rapporto corrente)
1.9
4.9
Quick Ratio
1.3
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
TMO
Mediana dei peer
Revenue YoY (Ricavi YoY)
3.9%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
-0.27%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
6.7%
—
EPS YoY
7.3%
—
Net Income YoY (Utile Netto YoY)
5.8%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
TMO
Mediana dei peer
Payout Ratio (Rapporto di Distribuzione Utili)
9.5%
—
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
Dividend Yield
0.25%
Rapporto di Distribuzione Utili
9.5%
CAGR Dividendi 5Y
—
| Data ex-dividendo | Importo |
|---|---|
| 15 Giugno 2026 | $0,4700 |
| 13 Marzo 2026 | $0,4700 |
| 15 Dicembre 2025 | $0,4300 |
| 15 Settembre 2025 | $0,4300 |
| 13 Giugno 2025 | $0,4300 |
| 14 Marzo 2025 | $0,4300 |
| 13 Dicembre 2024 | $0,3900 |
| 13 Settembre 2024 | $0,3900 |
| 14 Giugno 2024 | $0,3900 |
| 14 Marzo 2024 | $0,3900 |
| 14 Dicembre 2023 | $0,3500 |
| 14 Settembre 2023 | $0,3500 |
| 14 Giugno 2023 | $0,3500 |
| 14 Marzo 2023 | $0,3500 |
| 14 Dicembre 2022 | $0,3000 |
| 14 Settembre 2022 | $0,3000 |
| 14 Giugno 2022 | $0,3000 |
| 15 Marzo 2022 | $0,3000 |
| 14 Dicembre 2021 | $0,2600 |
| 14 Settembre 2021 | $0,2600 |
TMO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
36 analisti
- Acquisto forte 11 30,6%
- Compra 18 50,0%
- Mantieni 7 19,4%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
26 analisti · 2026-08-14
Mediana
$642.50
Ora
$590.93
Basso
$520.00
Alto
$750.00
Target mediano
$642.50
+8,7%
Target medio
$631.42
+6,9%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.13%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $6.03 | $5.77 | 0.26% |
| 31 Marzo 2026 | $5.44 | $5.29 | 0.15% |
| 31 Dicembre 2025 | $6.57 | $6.51 | 0.06% |
| 30 Settembre 2025 | $5.79 | $5.55 | 0.24% |
| 30 Giugno 2025 | $5.36 | $5.28 | 0.08% |
| 31 Marzo 2025 | $5.15 | $5.15 | -0.00% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | — |
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | — |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | — |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | — |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 17
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.56B | $42.88B | $42.86B | $44.91B | $39.21B | $32.22B | $25.54B | $24.36B | · | $18.27B | $16.96B | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | $8.21B | $7.58B | |
| R&D Expense | $1.40B | $1.39B | $1.34B | $1.47B | $1.41B | $1.18B | $1.00B | $967M | · | $754M | $692M | |
| SG&A Expense | $8.73B | $8.60B | $8.45B | $8.99B | $8.01B | $6.93B | $6.14B | $6.06B | · | $4.97B | $4.61B | |
| Operating Expenses | $36.81B | $35.54B | $36.00B | $36.52B | $29.18B | $24.42B | $20.95B | $20.57B | · | $15.82B | $14.63B | |
| Operating Income | $7.75B | $7.34B | $6.86B | $8.39B | $10.03B | $7.79B | $4.59B | $3.78B | · | $2.46B | $2.34B | |
| Interest Expense | · | · | $1.38B | $726M | $536M | $553M | $676M | $667M | · | $469M | $415M | |
| Interest Income | $993M | $1.08B | $879M | $272M | $43M | $65M | $224M | $137M | · | $48M | $31M | |
| Other Non-op | $-12M | $12M | $-65M | $-104M | $-694M | $-76M | $-70M | $9M | · | $-13M | $-16M | |
| Pretax Income | $7.31B | $7.04B | $6.30B | $7.83B | $8.84B | $7.23B | $4.07B | $3.26B | · | $2.02B | $1.94B | |
| Income Tax | $547M | $657M | $284M | $703M | $1.11B | $850M | $374M | $324M | · | $-1M | $-44M | |
| Net Income | $6.70B | $6.33B | $6.00B | $6.96B | $7.73B | $6.38B | $3.70B | · | · | · | · | |
| EPS (Basic) | $17.77 | $16.58 | $15.52 | $17.75 | $19.62 | $16.09 | $9.24 | $7.31 | · | $5.12 | $4.96 | |
| EPS (Diluted) | $17.74 | $16.53 | $15.45 | $17.63 | $19.46 | $15.96 | $9.17 | $7.24 | · | $5.09 | $4.92 | |
| Shares (Basic) | 377,000,000 | 382,000,000 | 386,000,000 | 392,000,000 | 394,000,000 | 396,000,000 | 400,000,000 | 402,000,000 | · | 395,000,000 | 399,000,000 | |
| Shares (Diluted) | 378,000,000 | 383,000,000 | 388,000,000 | 394,000,000 | 397,000,000 | 399,000,000 | 403,000,000 | 406,000,000 | · | 397,000,000 | 402,000,000 | |
| EBITDA | $7.75B | $7.34B | $6.86B | $8.39B | $10.03B | $7.79B | $4.59B | $6.05B | · | $4.21B | $4.02B |
Stato Patrimoniale 28
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.85B | $4.01B | $8.08B | $8.52B | $4.48B | $10.32B | $2.40B | $2.10B | · | $786M | $452M | |
| Short-term Investments | $253M | $1.56B | $3M | · | · | · | · | · | · | · | · | |
| Receivables | $8.90B | $8.19B | $8.22B | $8.12B | $7.98B | $5.74B | $4.35B | $4.14B | $3.87B | $3.05B | $2.54B | |
| Inventory | $5.42B | $4.98B | $5.09B | $5.63B | $5.05B | $4.03B | $3.37B | $3.00B | $2.72B | $2.21B | $1.99B | |
| Other Current Assets | $2.61B | $1.96B | $1.76B | $1.64B | $1.64B | $1.13B | $1.17B | $922M | $1.47B | $595M | $534M | |
| Current Assets | $28.71B | $22.14B | $24.59B | $25.23B | $20.11B | $21.96B | $11.89B | $10.62B | · | $7.02B | $5.74B | |
| PP&E (Net) | $10.56B | $9.31B | $9.45B | $9.28B | $8.33B | $5.91B | $4.75B | $4.17B | · | $2.58B | $2.45B | |
| PP&E (Gross) | $18.38B | $16.06B | $15.52B | $14.27B | $12.59B | $9.58B | $7.76B | $6.82B | · | $4.42B | $4.11B | |
| Accum. Depreciation | $7.82B | $6.75B | $6.08B | $4.99B | $4.26B | $3.67B | $3.02B | $2.65B | · | $1.84B | $1.66B | |
| Goodwill | $49.36B | $45.85B | $44.02B | $41.20B | $41.92B | $26.04B | $25.71B | $25.35B | · | $21.33B | $18.83B | |
| Intangibles | $15.84B | $15.53B | $16.67B | $17.44B | $20.11B | $12.69B | $14.01B | $14.98B | · | $13.97B | $12.76B | |
| Other Non-current Assets | $5.87B | $4.49B | $4.00B | $4.01B | $4.64B | $2.46B | $2.01B | $1.12B | $1.17B | $1.01B | $1.06B | |
| Total Assets | $110.34B | $97.32B | $98.73B | $97.15B | $95.12B | $69.05B | $58.38B | $56.23B | · | $45.91B | $40.83B | |
| Accounts Payable | $3.62B | $3.08B | $2.87B | $3.38B | $2.87B | $2.17B | $1.92B | $1.61B | · | $926M | $822M | |
| Short-term Debt | · | · | · | · | · | · | · | $693M | · | $953M | $50M | |
| Current Liabilities | $15.19B | $13.33B | $14.01B | $17.01B | $13.44B | $10.30B | $6.20B | $6.15B | · | $4.87B | $4.15B | |
| Capital Leases | $1.20B | $1.24B | $1.24B | $1.31B | $1.20B | $626M | $571M | · | · | · | · | |
| Deferred Tax | $1.49B | $1.27B | $1.92B | $2.85B | $3.84B | $1.79B | $2.19B | $2.27B | $2.71B | $2.56B | $2.62B | |
| Other Non-current Liabilities | $4.27B | $3.99B | $4.64B | $4.24B | $4.54B | $3.33B | $3.24B | $2.52B | $2.64B | $1.57B | $1.29B | |
| Long-term Debt | $39.17B | $31.07B | $34.73B | $34.28B | $34.67B | $21.73B | $17.75B | $18.99B | · | · | · | |
| Total Debt | · | · | · | · | · | $19.11B | $17.08B | $693M | · | $953M | $50M | |
| Common Stock | $445M | $444M | $442M | $441M | $439M | $437M | $434M | $432M | · | $415M | $412M | |
| Retained Earnings | $59.16B | $53.10B | $47.36B | $41.91B | $35.43B | $28.12B | $22.09B | $18.70B | $16.03B | $13.93B | $12.14B | |
| Treasury Stock | $22.31B | $19.23B | $15.13B | $12.02B | $8.92B | $6.82B | $5.24B | $3.67B | · | $2.31B | $1.01B | |
| AOCI | $-2.45B | $-2.70B | $-3.22B | $-3.10B | $-2.33B | $-2.81B | $-2.68B | $-2.50B | $-2.09B | $-2.64B | $-2.00B | |
| Stockholders' Equity | $53.41B | $49.58B | $46.73B | $43.98B | $40.79B | $34.51B | $29.68B | $27.59B | · | $21.54B | $21.35B | |
| Liabilities + Equity | $110.34B | $97.32B | $98.73B | $97.15B | $95.12B | $69.05B | $58.38B | $56.23B | · | $45.91B | $40.83B | |
| Shares Outstanding | 445,000,000 | 444,000,000 | 442,000,000 | 441,000,000 | 439,000,000 | 437,000,000 | 434,000,000 | · | · | · | · |
Flusso di cassa 19
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $2.27B | · | $1.76B | $1.69B | |
| Stock-based Comp | $310M | $301M | $278M | $307M | $230M | $196M | $181M | $181M | · | $133M | $125M | |
| Deferred Tax | $-639M | $-1.21B | $-1.30B | $-997M | $-645M | $-269M | $-499M | $-474M | · | $-639M | $-600M | |
| Amort. of Intangibles | $1.73B | $1.95B | $2.34B | $2.40B | $1.76B | $1.67B | $1.71B | $1.74B | · | $1.38B | $1.31B | |
| Restructuring | $197M | $97M | $194M | $68M | $37M | $51M | $52M | $88M | · | $167M | $90M | |
| Operating Cash Flow | $7.82B | $8.67B | $8.41B | $9.15B | $9.31B | $8.29B | $4.97B | $4.54B | · | $3.26B | $2.94B | |
| CapEx | $1.52B | $1.40B | $1.48B | $2.24B | $2.52B | $1.47B | $926M | $758M | · | $444M | $423M | |
| Investing Cash Flow | $-4.05B | $-5.84B | $-5.14B | $-2.16B | $-21.93B | $-1.51B | $-1.49B | $-1.25B | · | $-5.52B | $-1.09B | |
| Debt Issued | $7.76B | $1.20B | $5.94B | $3.19B | $18.14B | $3.46B | $5.64B | $690M | · | $7.60B | $1.80B | |
| Net Debt Issued | $5.35B | $-2.40B | $160M | $2.82B | $6.40B | $2.75B | $-722M | $-1.36B | · | $3.27B | $-1.98B | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | $0 | $0 | |
| Stock Repurchased | $3.00B | $4.00B | $3.00B | $3.00B | $2.00B | $1.50B | $1.50B | $500M | · | $1.25B | $500M | |
| Net Stock Activity | $-3.00B | $-4.00B | $-3.00B | $-3.00B | $-2.00B | $-1.50B | $-1.50B | $-500M | · | $-1.25B | $-500M | |
| Dividends Paid | $636M | $583M | $523M | $455M | $395M | $337M | $297M | $266M | · | $238M | $241M | |
| Financing Cash Flow | $1.80B | $-6.79B | $-3.62B | $-2.81B | $6.58B | $959M | $-3.12B | $-2.24B | · | $2.76B | $-2.62B | |
| Net Change in Cash | $5.84B | $-4.06B | $-440M | $4.05B | $-5.84B | $7.91B | $305M | $756M | · | $345M | $-898M | |
| Taxes Paid | $1.78B | $1.83B | $1.48B | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $6.29B | $7.27B | $6.93B | $6.91B | $6.79B | $6.82B | $4.05B | $3.79B | · | $2.71B | $2.39B | |
| Levered FCF | · | · | $5.61B | $6.25B | $6.32B | $6.33B | $3.43B | $3.18B | · | $2.24B | $1.97B |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 17.4% | 17.1% | 16.0% | 18.7% | 25.6% | 24.2% | 18.0% | 15.5% | · | 13.4% | 13.8% | |
| Net Margin | 15.0% | 14.8% | 13.9% | 15.5% | 19.7% | · | · | · | · | · | · | |
| Pretax Margin | 16.4% | 16.4% | 14.7% | 17.4% | 22.6% | 22.4% | 15.9% | 13.4% | · | 11.1% | 11.4% | |
| EBITDA Margin | 17.4% | 17.1% | 16.0% | 18.7% | 25.6% | 24.2% | 18.0% | 24.8% | · | 23.0% | 23.7% | |
| ROA | 6.5% | 6.4% | 6.1% | 7.2% | 9.4% | · | · | · | · | · | · | |
| ROE | 13.0% | 13.2% | 13.1% | 16.4% | 19.9% | · | · | · | · | · | · | |
| ROIC | 13.4% | 13.4% | 14.0% | 17.4% | 21.5% | 12.8% | 8.9% | 12.0% | · | 10.9% | 11.2% |
Liquidità e Solvibilità 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.7 | 1.8 | 1.5 | 1.5 | 2.1 | 1.9 | 1.7 | · | 1.4 | 1.4 | |
| Quick Ratio | 1.3 | 1.0 | 1.2 | 1.0 | 0.9 | 1.6 | 1.1 | 1.0 | · | 0.8 | 0.7 | |
| Debt / Equity | · | · | · | · | · | 0.6 | 0.6 | 0.0 | · | 0.0 | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | 0.6 | 0.6 | · | · | · | · | |
| Interest Coverage | · | · | 5.0 | 11.6 | 18.7 | 14.1 | 6.8 | 5.7 | · | 5.2 | 5.6 |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | · | 0.4 | 0.4 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | 3.9 | 3.9 | |
| Receivables Turnover | 5.2 | 5.2 | 5.2 | 5.6 | 5.7 | 6.4 | 6.0 | 6.1 | · | 6.5 | 6.8 |
Tassi di Crescita 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.9% | 0.05% | -4.6% | 14.5% | 21.7% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.27% | 3.0% | 10.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.7% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 7.3% | 7.0% | -12.4% | -9.4% | 21.9% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 0.21% | -5.3% | -1.1% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 2.1% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 5.8% | 5.7% | -13.9% | -9.9% | 21.2% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -1.2% | -6.4% | -2.0% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 1.0% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 13.5% | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 12
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.56B | $42.88B | $42.86B | $44.91B | $39.21B | $32.22B | $25.54B | $24.36B | · | $18.27B | $16.96B | |
| Net Income TTM | $6.70B | $6.33B | $6.00B | $6.96B | $7.73B | $6.38B | $3.70B | $1.48B | · | $1.48B | $1.48B | |
| Market Cap | $257.86B | $230.98B | $234.61B | $242.85B | · | · | · | · | · | · | · | |
| P/E | 32.7 | 31.5 | 34.4 | 31.2 | 34.3 | 29.2 | 35.4 | 30.9 | · | 27.7 | 28.8 | |
| P/S | 5.8 | 5.4 | 5.5 | 5.4 | · | · | · | · | · | · | · | |
| P/B | 4.8 | 4.7 | 5.0 | 5.5 | · | · | · | · | · | · | · | |
| P / Cash Flow | 33.0 | 26.7 | 27.9 | 26.5 | · | · | · | · | · | · | · | |
| P / FCF | 41.0 | 31.8 | 33.9 | 35.1 | · | · | · | · | · | · | · | |
| Dividend Yield | 0.25% | 0.25% | 0.22% | 0.19% | · | · | · | · | · | · | · | |
| Earnings Yield | 3.1% | 3.2% | 2.9% | 3.2% | 2.9% | 3.4% | 2.8% | 3.2% | · | 3.6% | 3.5% | |
| Payout Ratio | 9.5% | 9.2% | 8.8% | 6.5% | 5.1% | · | · | · | · | · | · | |
| Annual Payout | $636M | $583M | $523M | $455M | $395M | $337M | $297M | $266M | · | $238M | $241M |
Conto Economico 16
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.99B | $11.01B | $12.21B | $11.12B | $10.86B | $10.36B | $11.39B | $10.60B | $10.54B | $10.35B | $10.89B | $10.57B | $10.71B | $11.45B | |
| R&D Expense | $364M | $336M | $357M | $346M | $352M | $342M | $374M | $346M | $339M | $331M | $327M | $319M | $346M | $391M | |
| SG&A Expense | $2.33B | $2.18B | $2.35B | $2.16B | $2.14B | $2.08B | $2.20B | $2.10B | $2.11B | $2.18B | $2.13B | $2.05B | $2.12B | $2.30B | |
| Operating Expenses | $9.91B | $9.14B | $9.96B | $9.18B | $9.02B | $8.65B | $9.38B | $8.76B | $8.72B | $8.68B | $9.03B | $8.71B | $9.15B | $9.59B | |
| Operating Income | $2.09B | $1.86B | $2.25B | $1.94B | $1.83B | $1.72B | $2.02B | $1.84B | $1.82B | $1.66B | $1.85B | $1.86B | $1.56B | $1.86B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $363M | · | $359M | $300M | · | |
| Interest Income | $207M | $233M | $259M | $234M | $297M | $203M | $227M | $277M | $295M | $279M | $309M | $246M | $146M | $150M | |
| Other Non-op | $31M | $-9M | $6M | $-2M | $-19M | $3M | $13M | $-16M | $5M | $10M | $-33M | $14M | $-46M | $35M | |
| Pretax Income | $1.92B | $1.73B | $2.15B | $1.83B | $1.71B | $1.62B | $1.94B | $1.74B | $1.76B | $1.59B | $1.74B | $1.76B | $1.36B | $1.78B | |
| Income Tax | $167M | $70M | $153M | $207M | $92M | $95M | $149M | $99M | $128M | $281M | $133M | $53M | $46M | $173M | |
| Net Income | $1.74B | $1.65B | $1.96B | $1.62B | $1.62B | $1.51B | $1.83B | $1.63B | $1.55B | $1.33B | $1.65B | $1.70B | $1.29B | $1.57B | |
| EPS (Basic) | $4.68 | $4.44 | $5.22 | $4.28 | $4.28 | $3.99 | $4.80 | $4.26 | $4.05 | $3.47 | $4.21 | $4.44 | $3.34 | $4.03 | |
| EPS (Diluted) | $4.68 | $4.43 | $5.21 | $4.27 | $4.28 | $3.98 | $4.78 | $4.25 | $4.04 | $3.46 | $4.20 | $4.42 | $3.32 | $4.01 | |
| Shares (Basic) | 371,000,000 | 372,000,000 | -757,000,000 | 378,000,000 | 378,000,000 | 378,000,000 | -764,000,000 | 382,000,000 | 382,000,000 | 382,000,000 | 0 | 386,000,000 | 386,000,000 | 0 | |
| Shares (Diluted) | 371,000,000 | 373,000,000 | -757,000,000 | 378,000,000 | 378,000,000 | 379,000,000 | -768,000,000 | 384,000,000 | 383,000,000 | 384,000,000 | 0 | 388,000,000 | 388,000,000 | -1,000,000 | |
| EBITDA | $2.09B | $1.86B | · | $1.94B | $1.83B | $1.72B | · | $1.84B | $1.82B | $1.66B | · | $1.86B | $1.56B | · |
Stato Patrimoniale 26
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.06B | $3.25B | $9.85B | $1.98B | $4.58B | $4.13B | $4.01B | $4.64B | $7.07B | $5.50B | · | $6.15B | $3.48B | · | |
| Short-term Investments | $0 | $2M | $253M | $1.56B | $1.81B | $1.81B | $1.56B | $2.00B | $1.75B | $1.75B | · | · | · | · | |
| Receivables | $9.45B | $9.20B | $8.90B | $8.91B | $8.59B | $8.46B | $8.19B | $8.26B | $7.94B | $7.93B | · | $8.37B | $7.92B | · | |
| Inventory | $5.63B | $5.50B | $5.42B | $5.75B | $5.56B | $5.22B | $4.98B | $5.43B | $5.20B | $5.13B | · | $5.40B | $5.66B | · | |
| Other Current Assets | $2.54B | $2.68B | $2.61B | $2.47B | $2.60B | $2.39B | $1.96B | $1.91B | $2.02B | $1.90B | · | $1.70B | $1.77B | · | |
| Current Assets | $23.36B | $22.32B | $28.71B | $22.30B | $24.58B | $23.38B | $22.14B | $23.78B | $25.48B | $23.64B | · | $23.09B | $20.21B | · | |
| PP&E (Net) | $10.76B | $10.66B | $10.56B | $10.18B | $9.63B | $9.33B | $9.31B | $9.41B | $9.28B | $9.32B | · | $9.17B | $9.35B | · | |
| PP&E (Gross) | · | · | $18.38B | · | · | · | $16.06B | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $7.82B | · | · | · | $6.75B | · | · | · | · | · | · | · | |
| Goodwill | $54.83B | $55.19B | $49.36B | $49.29B | $47.25B | $46.49B | $45.85B | $46.73B | $43.84B | $43.84B | $44.02B | $43.58B | $43.14B | $41.20B | |
| Intangibles | $18.61B | $19.15B | $15.84B | $16.24B | $15.15B | $15.32B | $15.53B | $16.26B | $15.52B | $16.05B | · | $17.09B | $17.97B | · | |
| Other Non-current Assets | $5.62B | $5.97B | $5.87B | $5.02B | $4.62B | $4.52B | $4.49B | $4.18B | $4.38B | $4.24B | · | $4.12B | $3.98B | · | |
| Total Assets | $113.17B | $113.28B | $110.34B | $103.02B | $101.23B | $99.04B | $97.32B | $100.36B | $98.50B | $97.09B | $98.73B | $97.06B | $94.66B | $97.15B | |
| Accounts Payable | $3.27B | $3.34B | $3.62B | $3.12B | $2.98B | $3.05B | $3.08B | $2.61B | $2.55B | $2.56B | · | $2.51B | $2.80B | · | |
| Current Liabilities | $15.07B | $14.62B | $15.19B | $14.89B | $12.72B | $13.17B | $13.33B | $14.60B | $14.77B | $13.94B | · | $14.16B | $15.88B | · | |
| Capital Leases | · | · | $1.20B | · | · | · | $1.24B | · | · | · | · | · | · | · | |
| Deferred Tax | $1.58B | $2.11B | $1.49B | $842M | $624M | $1.04B | $1.27B | $1.12B | $1.52B | $1.81B | · | $2.62B | $2.98B | · | |
| Other Non-current Liabilities | $4.54B | $4.42B | $4.27B | $4.28B | $4.27B | $3.97B | $3.99B | $4.34B | $4.39B | $4.57B | · | $4.33B | $4.23B | · | |
| Long-term Debt | $42.28B | $42.95B | $39.17B | $35.48B | $35.03B | $33.99B | $31.07B | $35.11B | $35.20B | $35.39B | · | $35.08B | $35.05B | · | |
| Common Stock | $446M | $445M | $445M | $445M | $444M | $444M | $444M | $444M | $443M | $443M | · | $442M | $441M | · | |
| Retained Earnings | $62.19B | $60.63B | $59.16B | $57.35B | $55.90B | $54.45B | $53.10B | $51.42B | $49.94B | $48.54B | · | $45.87B | $43.06B | · | |
| Treasury Stock | $26.37B | $25.36B | $22.31B | $22.31B | $21.27B | $21.27B | $19.23B | $18.23B | $18.19B | $18.19B | · | $15.12B | $15.08B | · | |
| AOCI | $-2.46B | $-2.50B | $-2.45B | $-2.80B | $-2.80B | $-2.34B | $-2.70B | $-2.48B | $-2.41B | $-2.76B | · | $-3.03B | $-3.05B | · | |
| Stockholders' Equity | $52.68B | $51.93B | $53.41B | $51.02B | $50.51B | $49.39B | $49.58B | $48.99B | $47.43B | $45.52B | · | $45.33B | $42.26B | · | |
| Liabilities + Equity | $113.17B | $113.28B | $110.34B | $103.02B | $101.23B | $99.04B | $97.32B | $100.36B | $98.50B | $97.09B | · | $97.06B | $94.66B | · | |
| Shares Outstanding | 446,000,000 | 445,000,000 | 445,000,000 | 445,000,000 | 444,000,000 | 444,000,000 | 444,000,000 | 444,000,000 | 443,000,000 | 443,000,000 | 442,000,000 | 442,000,000 | 441,000,000 | 441,000,000 |
Flusso di cassa 16
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $82M | $83M | $84M | $70M | $81M | $75M | $79M | $68M | $84M | $70M | $61M | $67M | $76M | $75M | |
| Deferred Tax | $-208M | $-258M | $89M | $-127M | $-322M | $-279M | $-202M | $-400M | · | · | · | · | · | · | |
| Amort. of Intangibles | $485M | $430M | $436M | $435M | $430M | $429M | $438M | $449M | $514M | $551M | $563M | $584M | $606M | $592M | |
| Restructuring | $38M | $34M | $36M | $62M | $56M | $43M | $20M | $26M | $26M | $25M | $19M | $38M | $50M | $37M | |
| Operating Cash Flow | $2.12B | $1.19B | $3.46B | $2.24B | $1.40B | $723M | $3.29B | $2.17B | $1.96B | $1.25B | $3.72B | $2.41B | $729M | $3.49B | |
| CapEx | $450M | $376M | $465M | $404M | $294M | $362M | $480M | $272M | $301M | $347M | $405M | $332M | $458M | $550M | |
| Investing Cash Flow | $164M | $-8.96B | $891M | $-4.12B | $-288M | $-527M | $20M | $-3.58B | $-253M | $-2.03B | $-376M | $-1.18B | $-3.14B | $-525M | |
| Debt Issued | $0 | $5.24B | $4.92B | $0 | $0 | $2.84B | $0 | $0 | $-1M | $1.21B | $2.48B | $3.47B | $0 | $3.19B | |
| Net Debt Issued | · | $3.83B | · | · | · | $2.00B | · | · | · | $1.21B | · | · | $0 | · | |
| Stock Repurchased | $1.00B | $3.00B | $37M | $963M | $0 | $2.00B | $1.00B | $0 | $0 | $3.00B | $0 | $0 | $3.00B | $1.00B | |
| Net Stock Activity | · | $-3.00B | · | · | · | $-2.00B | · | · | · | $-3.00B | · | · | $-3.00B | · | |
| Dividends Paid | $175M | $162M | $162M | $163M | $162M | $149M | $149M | $150M | $149M | $135M | $136M | $135M | $117M | $117M | |
| Financing Cash Flow | $-1.57B | $1.09B | $3.53B | $-632M | $-991M | $-102M | $-3.67B | $-1.19B | $-115M | $-1.82B | $-1.43B | $1.85B | $-2.59B | $2.39B | |
| Net Change in Cash | $817M | $-6.60B | $7.87B | $-2.59B | $431M | $132M | $-630M | $-2.43B | $1.58B | $-2.58B | $1.93B | $3.02B | $-5.04B | $5.60B | |
| Free Cash Flow | · | $816M | · | · | · | $361M | · | · | · | $904M | · | · | $271M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $605M | · | · | $-19M | · |
Redditività 7
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 17.4% | 16.9% | · | 17.4% | 16.9% | 16.6% | · | 17.3% | 17.3% | 16.1% | · | 17.6% | 14.6% | · | |
| Net Margin | 14.5% | 15.0% | · | 14.5% | 14.9% | 14.6% | · | 15.4% | 14.7% | 12.9% | · | 16.0% | 12.1% | · | |
| Pretax Margin | 16.0% | 15.8% | · | 16.4% | 15.7% | 15.6% | · | 16.4% | 16.7% | 15.4% | · | 16.7% | 12.7% | · | |
| EBITDA Margin | 17.4% | 16.9% | · | 17.4% | 16.9% | 16.6% | · | 17.3% | 17.3% | 16.1% | · | 17.6% | 14.6% | · | |
| ROA | 1.6% | 1.6% | · | 1.6% | 1.6% | 1.5% | · | 1.7% | 1.6% | 1.4% | · | 1.8% | · | · | |
| ROE | 3.4% | 3.3% | · | 3.2% | 3.3% | 3.2% | · | 3.5% | 3.4% | 3.0% | · | 3.8% | · | · | |
| ROIC | 3.6% | 3.4% | · | 3.4% | 3.4% | 3.3% | · | 3.5% | 3.6% | 3.0% | · | 4.0% | · | · |
Liquidità e Solvibilità 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.5 | · | 1.5 | 1.9 | 1.8 | · | 1.6 | 1.7 | 1.7 | · | 1.6 | · | · | |
| Quick Ratio | 0.9 | 0.9 | · | 0.8 | 1.2 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 4.6 | · | 5.2 | 5.2 | · |
Efficienza 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | · | |
| Receivables Turnover | 1.3 | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.98B | $43.35B | · | $42.94B | $42.36B | $41.85B | · | $42.06B | $42.15B | $42.32B | · | $42.65B | $44.17B | · | |
| Net Income TTM | $6.62B | $6.39B | · | $6.37B | $6.31B | $6.02B | · | $6.20B | $5.94B | $5.68B | · | $5.85B | $6.68B | · | |
| Market Cap | $228.81B | $210.65B | · | $206.59B | $181.28B | $222.07B | · | $272.80B | $244.98B | $257.48B | · | $223.73B | · | · | |
| P/E | 29.1 | 27.9 | · | 27.7 | 24.7 | 31.8 | · | 38.0 | 35.8 | 39.5 | · | 33.7 | 34.0 | · | |
| P/S | 5.1 | 4.9 | · | 4.8 | 4.3 | 5.3 | · | 6.5 | 5.8 | 6.1 | · | 5.2 | · | · | |
| P/B | 4.3 | 4.1 | · | 4.0 | 3.6 | 4.5 | · | 5.6 | 5.2 | 5.7 | · | 4.9 | · | · | |
| P / Cash Flow | · | 176.7 | · | · | · | 307.2 | · | · | · | 205.8 | · | · | · | · | |
| P / FCF | · | 258.1 | · | · | · | 615.2 | · | · | · | 284.8 | · | · | · | · | |
| Earnings Yield | 3.4% | 3.6% | · | 3.6% | 4.0% | 3.1% | · | 2.6% | 2.8% | 2.5% | · | 3.0% | 2.9% | · | |
| Payout Ratio | · | 9.8% | · | · | · | 9.9% | · | · | · | 10.1% | · | · | 9.1% | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2025-06-28 | 2025-03-29 | 2024-12-31 | 2024-09-28 | |
|---|---|---|---|---|---|
| Ricavi | $44.56B | — | — | $42.88B | — |
| Margine Operativo % | 17.4% | — | — | 17.1% | — |
| Utile netto | $6.70B | — | — | $6.33B | — |
| EPS Diluito | $17.74 | — | — | $16.53 | — |
Stato Patrimoniale
| 2025-12-31 | 2025-06-28 | 2025-03-29 | 2024-12-31 | 2024-09-28 | |
|---|---|---|---|---|---|
| Rapporto corrente | 1.9 | — | — | 1.7 | — |
| Quick Ratio | 1.3 | — | — | 1.0 | — |
Flusso di cassa
| 2025-12-31 | 2025-06-28 | 2025-03-29 | 2024-12-31 | 2024-09-28 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $6.29B | — | — | $7.27B | — |
Ultime notizie Notizie recenti che menzionano questa società
- Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings?
- I piace agli analisti di Wall Street il titolo Thermo Fisher Scientific?
- Thermo Fisher Scientific Inc. (TMO) svela il Bioprocess Design Center per sviluppare terapie che cambiano la vita
- Jim Cramer su Thermo Fisher: “Penso che si possa comprare a questo livello”
- TD Cowen Abbassa il Prezzo Target di Thermo Fisher (TMO), Mantiene il Rating Buy
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 2.893 filer · $107.2B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 196 (-6 vs trimestre precedente) | 140 (-78 vs trimestre precedente) | 925 (-41 vs trimestre precedente) | 1.116 (+29 vs trimestre precedente) | +59.7M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $12.171.173.789 | 24.276.316 | 11,35% | Azioni |
| STATE STREET CORP | $8.443.627.719 | 16.825.879 | 7,87% | Azioni |
| FMR LLC | $4.526.822.682 | 9.029.086 | 4,22% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $3.572.029.397 | 7.164.352 | 3,33% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.121.552.090 | 6.226.169 | 2,91% | Azioni |
| Capital World Investors | $3.106.193.041 | 6.195.370 | 2,90% | Azioni |
| NORGES BANK | $2.550.871.048 | 5.087.903 | 2,38% | Azioni |
| Capital Research Global Investors | $2.079.461.815 | 4.147.545 | 1,94% | Azioni |
| Capital International Investors | $1.595.416.232 | 3.182.151 | 1,49% | Azioni |
| Dodge & Cox | $1.531.543.498 | 3.054.778 | 1,43% | Azioni |
| Fisher Asset Management, LLC | $1.461.823.432 | 2.915.715 | 1,36% | Azioni |
| Grantham, Mayo, Van Otterloo & Co. LLC | $1.373.321.891 | 2.739.191 | 1,28% | Azioni |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $1.371.130.859 | 2.734.823 | 1,28% | Azioni |
| EdgePoint Investment Group Inc. | $1.092.789.324 | 2.179.650 | 1,02% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $1.046.130.256 | 2.086.585 | 0,98% | Azioni |
| Unisphere Establishment | $1.032.801.600 | 2.060.000 | 0,96% | Azioni |
| Mitsubishi UFJ Asset Management Co., Ltd. | $1.009.204.590 | 2.012.934 | 0,94% | Azioni |
| PRIMECAP MANAGEMENT CO/CA/ | $993.831.390 | 1.982.271 | 0,93% | Azioni |
| VIKING GLOBAL INVESTORS LP | $971.342.384 | 1.937.415 | 0,91% | Azioni |
| FLOSSBACH VON STORCH SE | $955.579.626 | 1.905.975 | 0,89% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $908.857.157 | 1.849.037 | 0,85% | Azioni |
| 1832 Asset Management L.P. | $863.062.662 | 1.721.443 | 0,80% | Azioni |
| Clearbridge Investments, LLC | $847.834.531 | 1.691.069 | 0,79% | Azioni |
| PARNASSUS INVESTMENTS, LLC | $822.024.341 | 1.639.589 | 0,77% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $768.919.799 | 1.533.667 | 0,72% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $667.185.605 | 1.330.750 | 0,62% | Azioni |
| Temasek Holdings (Private) Ltd | $583.447.171 | 1.163.729 | 0,54% | Azioni |
| BlackRock, Inc. | $579.344.543 | 1.155.546 | 0,54% | Azioni |
| LOOMIS SAYLES & CO L P | $571.001.278 | 1.138.905 | 0,53% | Azioni |
| LAZARD ASSET MANAGEMENT LLC | $567.301.499 | 1.131.525 | 0,53% | Azioni |
| Sumitomo Mitsui Trust Group, Inc. | $541.170.491 | 1.079.405 | 0,50% | Azioni |
| Pictet Asset Management Holding SA | $538.406.962 | 1.073.670 | 0,50% | Azioni |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $526.019.392 | 1.049.185 | 0,49% | Azioni |
| Swiss National Bank | $525.485.443 | 1.048.120 | 0,49% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $505.067.056 | 1.007.394 | 0,47% | Azioni |
| Rathbones Group PLC | $504.097.425 | 1.005.460 | 0,47% | Azioni |
| UBS Group AG | $503.596.066 | 1.004.460 | 0,47% | Azioni |
| BANK OF AMERICA CORP /DE/ | $488.690.042 | 974.729 | 0,46% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $450.916.165 | 899.386 | 0,42% | Azioni |
| Veritas Asset Management LLP | $442.637.207 | 882.873 | 0,41% | Azioni |
| Focus Partners Wealth | $431.444.332 | 860.536 | 0,40% | Azioni |
| FIRST MANHATTAN CO. LLC. | $422.447.886 | 841.894 | 0,39% | Azioni |
| National Pension Service | $422.118.548 | 841.947 | 0,39% | Azioni |
| GOLDMAN SACHS GROUP INC | $417.251.345 | 832.239 | 0,39% | Azioni |
| D1 Capital Partners L.P. | $409.672.787 | 817.123 | 0,38% | Azioni |
| W1M Asset Management Ltd | $408.009.352 | 814.886 | 0,38% | Azioni |
| Vanguard Global Advisers, LLC | $401.921.762 | 801.663 | 0,37% | Azioni |
| Legal & General Group Plc | $393.992.751 | 785.848 | 0,37% | Azioni |
| BARCLAYS PLC | $383.005.951 | 763.934 | 0,36% | Azioni |
| AMERIPRISE FINANCIAL INC | $373.268.191 | 744.431 | 0,35% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $369.918.950 | 737.831 | 0,34% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $365.892.528 | 729.800 | 0,34% | Azioni |
| VANGUARD GROUP INC | $354.408.424 | 611.629 | 0,33% | Azioni |
| California Public Employees Retirement System | $349.327.092 | 696.759 | 0,33% | Azioni |
| KING LUTHER CAPITAL MANAGEMENT CORP | $339.577.646 | 677.313 | 0,32% | Azioni |
| W1M Investment Management Ltd | $335.034.706 | 691.342 | 0,31% | Azioni |
| NEUBERGER BERMAN GROUP LLC | $321.963.477 | 642.176 | 0,30% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $319.519.265 | 637.305 | 0,30% | Azioni |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $314.473.046 | 627.240 | 0,29% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $309.344.243 | 616.961 | 0,29% | Azioni |
| CANADA PENSION PLAN INVESTMENT BOARD | $307.944.336 | 614.218 | 0,29% | Azioni |
| D. E. Shaw & Co., Inc. | $307.017.322 | 612.369 | 0,29% | Azioni |
| JANUS HENDERSON GROUP PLC | $301.030.667 | 612.436 | 0,28% | Azioni |
| RHUMBLINE ADVISERS | $297.780.694 | 593.946 | 0,28% | Azioni |
| Ninety One UK Ltd | $297.641.362 | 593.668 | 0,28% | Azioni |
| ENVESTNET ASSET MANAGEMENT INC | $296.956.107 | 592.301 | 0,28% | Azioni |
| Mirova US LLC | $296.432.610 | 591.257 | 0,28% | Azioni |
| Robeco Institutional Asset Management B.V. | $289.599.072 | 577.627 | 0,27% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $281.062.261 | 571.811 | 0,26% | Azioni |
| PRINCIPAL FINANCIAL GROUP INC | $274.562.786 | 547.636 | 0,26% | Azioni |
| Eurizon Capital SGR S.p.A. | $271.488.657 | 539.965 | 0,25% | Azioni |
| APG Asset Management N.V. | $266.543.464 | 607.825 | 0,25% | Azioni |
| Longview Partners (Guernsey) LTD | $265.608.495 | 529.776 | 0,25% | Azioni |
| CITADEL ADVISORS LLC | $263.486.238 | 525.543 | 0,25% | Azioni |
| Lindsell Train Ltd | $257.955.736 | 514.512 | 0,24% | Azioni |
| Southpoint Capital Advisors LP | $250.680.000 | 500.000 | 0,23% | Azioni |
| Qube Research & Technologies Ltd | $246.959.909 | 492.580 | 0,23% | Azioni |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | $245.733.399 | 490.134 | 0,23% | Azioni |
| CI INVESTMENTS INC. | $235.771.058 | 470.263 | 0,22% | Azioni |
| Balyasny Asset Management L.P. | $225.425.494 | 449.628 | 0,21% | Azioni |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | $223.014.454 | 444.819 | 0,21% | Azioni |
| JONES FINANCIAL COMPANIES LLLP | $221.174.247 | 431.114 | 0,21% | Azioni |
| ROYAL LONDON ASSET MANAGEMENT LTD | $217.246.307 | 433.314 | 0,20% | Azioni |
| M&G PLC | $214.820.283 | 428.783 | 0,20% | Azioni |
| Liontrust Investment Partners LLP | $211.478.390 | 364.964 | 0,20% | Azioni |
| Cryder Capital Partners LLP | $210.160.586 | 419.181 | 0,20% | Azioni |
| FIFTH THIRD BANCORP | $209.624.364 | 418.112 | 0,20% | Azioni |
| JANE STREET GROUP, LLC | $205.206.648 | 409.300 | 0,19% | Opzione Put |
| JANE STREET GROUP, LLC | $204.905.832 | 408.700 | 0,19% | Opzione Call |
| Ensign Peak Advisors, Inc | $204.085.607 | 407.064 | 0,19% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $203.978.817 | 406.851 | 0,19% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $203.629.369 | 406.154 | 0,19% | Azioni |
| AVIVA PLC | $202.744.469 | 404.389 | 0,19% | Azioni |
| Navera Investment Management Ltd. | $199.087.273 | 397.439 | 0,19% | Azioni |
| FIL Ltd | $198.044.720 | 395.015 | 0,18% | Azioni |
| CIBC Bancorp USA Inc. | $190.068.606 | 378.891 | 0,18% | Azioni |
| Alyeska Investment Group, L.P. | $188.546.957 | 376.071 | 0,18% | Azioni |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $187.568.351 | 373.510 | 0,17% | Azioni |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $180.518.000 | 360.056 | 0,17% | Azioni |
| Railway Pension Investments Ltd | $179.973.199 | 358.970 | 0,17% | Azioni |
Insider aziendali 60 insider · 29 dirigenti · 28 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Marijn E Dekkers | Chief Executive Officer | 17 Agosto 2009 F | 42.554 | 0 | 0 | $0 |
| Stephen Williamson | Retiring Sr. VP and CFO | 28 Febbraio 2026 F | 32.499 | 0 | 0 | $0 |
| Kyriazi Theo Melas | VP & Chief Financial Officer | 16 Settembre 2004 M | 158.199 | 0 | 0 | $0 |
| Gianluca Pettiti | President & COO | 27 Luglio 2026 S | 24.651 | 0 | 6 | $-2.582.704 |
| Mark Stevenson | Retiring Executive VP & COO | 25 Febbraio 2022 F | 62.141 | 0 | 0 | $0 |
| Frederick M. Lowery | Executive Vice President | 28 Febbraio 2026 F | 15.044 | 0 | 2 | $-8.154.131 |
| Michel Lagarde | Executive Vice President | 28 Febbraio 2026 F | 85.151 | 0 | 5 | $-51.307.290 |
| Thomas B Shropshire Jr. | SVP and General Counsel | 25 Febbraio 2026 A | 6.058 | 0 | 0 | $0 |
| Michael A Boxer | SVP and General Counsel | 10 Marzo 2025 S | 10.816 | 0 | 0 | $0 |
| Syed A. Jafry | Sr. Vice President | 26 Febbraio 2021 F | 22.349 | 0 | 0 | $0 |
| Peter E Hornstra | VP & Chief Accounting Officer | 26 Febbraio 2021 F | 1.962 | 0 | 0 | $0 |
| Patrick M Durbin | Senior Vice President | 28 Agosto 2019 F | 38.868 | 0 | 0 | $0 |
| Gregory J. Herrema | Senior Vice President | 28 Agosto 2019 F | 26.967 | 0 | 0 | $0 |
| Seth H Hoogasian | Sr. VP & Retiring Gen. Counsel | 28 Febbraio 2018 F | 26.530 | 0 | 0 | $0 |
| Shine Daniel P | Senior Vice President | 30 Agosto 2017 S | 20.682 | 0 | 0 | $0 |
| Thomas W Loewald | Senior Vice President | 28 Agosto 2017 F | 38.133 | 0 | 0 | $0 |
| Peter M Wilver | Exec. VP & Chief Admin Officer | 15 Marzo 2017 S | 62.517 | 0 | 0 | $0 |
| Alan J Malus | Executive Vice President | 10 Marzo 2016 M | 47.286 | 0 | 0 | $0 |
| Andrew J Thomson | Senior Vice President | 26 Agosto 2015 F | 52.389 | 0 | 0 | $0 |
| Edward A Pesicka | Senior Vice President | 05 Marzo 2015 M | 80.641 | 0 | 0 | $0 |
| Kenneth Berger | Senior Vice President | 26 Febbraio 2012 F | 36.128 | 0 | 0 | $0 |
| Stephen G Sheehan | Sr. VP, Human Resources | 05 Marzo 2010 F | 4.396 | 0 | 0 | $0 |
| Yuh-Geng Tsay | Senior Vice President | 26 Febbraio 2010 F | 110.369 | 0 | 0 | $0 |
| Alexander G Stachtiaris | Sr. VP, Global Bus. Services | 05 Marzo 2008 A | 17.236 | 0 | 0 | $0 |
| Fredric T Walder | Sr. VP, Customer Excellence | 05 Marzo 2008 A | 16.730 | 0 | 0 | $0 |
| Guy Broadbent | Senior Vice President | 05 Marzo 2008 A | 31.545 | 0 | 0 | $0 |
| Joseph R Massaro | Sr. VP, Global Bus. Services | 16 Novembre 2007 S | 15.000 | 0 | 0 | $0 |
| SYRON RICHARD F/CA | Executive Chairman | 12 Dicembre 2003 S | 80.320 | 0 | 0 | $0 |
| Barry S Howe | VP, Measurement & Control | 31 Luglio 2003 M | 23.247 | 0 | 0 | $0 |
| Alexandra R. Keith | Direttore | 27 Giugno 2026 A | 2.602 | 0 | 0 | $0 |
| Dion J Weisler | Direttore | 27 Giugno 2026 A | 5.446 | 0 | 0 | $0 |
| Karen S Lynch | Direttore | 27 Giugno 2026 A | 1.159 | 0 | 0 | $0 |
| Scott M Sperling | Direttore | 27 Giugno 2026 A | 69.479 | 0 | 0 | $0 |
| Jennifer M Johnson | Direttore | 27 Giugno 2026 A | 1.403 | 0 | 0 | $0 |
| Debora L Spar | Direttore | 20 Maggio 2026 A | 2.610 | 0 | 0 | $0 |
| Tyler Jacks | Direttore | 20 Maggio 2026 A | 9.462 | 0 | 0 | $0 |
| Ruby R Chandy | Direttore | 20 Maggio 2026 A | 3.463 | 0 | 0 | $0 |
| Nelson Chai | Direttore | 20 Maggio 2026 A | 15.316 | 0 | 0 | $0 |
| Martin C Harris | Direttore | 20 Maggio 2026 A | 9.532 | 0 | 0 | $0 |
| MULLEN JAMES C | Direttore | 21 Maggio 2025 A | 3.393 | 0 | 0 | $0 |
| Lars Rebien Sorensen | Direttore | 22 Maggio 2024 F | 9.233 | 0 | 0 | $0 |
| Jim P Manzi | Direttore | 03 Febbraio 2023 S | 14.807 | 0 | 0 | $0 |
| Thomas J Lynch | Direttore | 05 Novembre 2021 G | 10.257 | 0 | 0 | $0 |
| Judy C Lewent | Direttore | 20 Maggio 2020 A | 1.290 | 0 | 0 | $0 |
| Elaine Ullian | Direttore | 22 Maggio 2019 A | 4.706 | 0 | 0 | $0 |
| William G Parrett | Direttore | 23 Febbraio 2018 S | 11.660 | 0 | 0 | $0 |
| Michael E Porter | Direttore | 09 Marzo 2012 M | 14.640 | 0 | 0 | $0 |
| Peter J Manning | Direttore | 25 Maggio 2011 A | 6.548 | 0 | 0 | $0 |
| Michael Adam Bell | Direttore | 20 Maggio 2010 A | 8.192 | 0 | 0 | $0 |
| Stephen P Kaufman | Direttore | 20 Maggio 2010 A | 9.192 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 22 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Pharmaceutical Product Development, LLC, Wildcat Acquisition Holdings (UK) Limited, Jaguar Holding Company II, Jaguar Holding Company I, LLC, Eagle Holding Company II, LLC, PPD, Inc., Thermo Fisher Scientific Powder US Holdings Corp., Thermo Fisher Scientific Inc., Fisher Scientific International LLC, Fisher Scientific Worldwide Inc., Spectra-Physics Holdings USA, LLC, Thermo Fisher Scientific Powder Holdings I Ltd, Thermo Fisher Scientific Powder Holdings II Ltd, Thermo Fisher Scientific Powder Holdings III Ltd, Thermo Fisher Scientific Powder Holdings IV Ltd, Thermo Fisher Scientific Powder US Holdings Ltd ×2 depositi | 14 Marzo 2024 | — | Deposito iniziale | M&A / vendita | SEC |
| Thermo Fisher Scientific Inc., Thermo Fisher (CN) Luxembourg S.à r.l. ×2 depositi | 13 Settembre 2017 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 30 Giugno 2005 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 11 Maggio 2005 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 24 Marzo 2005 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 02 Marzo 2005 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 28 Luglio 2004 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 27 Luglio 2004 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 28 Ottobre 2003 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 17 Ottobre 2002 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 16 Ottobre 2002 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 04 Aprile 2002 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 01 Aprile 2002 | — | Deposito iniziale | — | SEC |
| Thermo Electron Corporation IRS No. ×5 depositi | 27 Dicembre 2001 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 21 Novembre 2001 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 213 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| GDOC · Goldman Sachs ETF Trust | 4,52% | 1.847 NS | 31 Maggio 2026 | N-PORT |
| AGIQ · Tidal Trust I | 3,99% | 918 NS | 31 Maggio 2026 | N-PORT |
| HRTS · Tema ETF Trust | 3,97% | 4.185 NS | 31 Maggio 2026 | N-PORT |
| IYH · iShares Trust | 3,51% | 222.608 SH | 08 Agosto 2026 | Giornaliero |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 3,19% | 740 NS | 30 Aprile 2026 | N-PORT |
| PRVS · Parnassus Funds II | 3,12% | 1.576 NS | 30 Giugno 2026 | N-PORT |
| QLTY · GMO ETF Trust | 2,94% | 269.227 NS | 31 Maggio 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 2,91% | 173.204 NS | 30 Aprile 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 2,74% | 1.117.168 SH | 08 Agosto 2026 | Giornaliero |
| IXJ · iShares Trust | 2,72% | 195.170 SH | 08 Agosto 2026 | Giornaliero |
| RXL · ProShares Trust | 2,68% | 3.918 NS | 31 Maggio 2026 | N-PORT |
| EQTY · Valued Advisers Trust | 2,66% | 72.927 NS | 30 Aprile 2026 | N-PORT |
| TOLL · Tema ETF Trust | 2,63% | 2.616 NS | 31 Maggio 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 2,59% | 7.491 NS | 30 Aprile 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 2,39% | 1.916 NS | 30 Aprile 2026 | N-PORT |
| KAT · Advisors Series Trust | 2,24% | 30.779 NS | 31 Marzo 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,99% | 2.213 NS | 30 Aprile 2026 | N-PORT |
| CAML · Professionally Managed Portfolios | 1,88% | 14.779 NS | 30 Aprile 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,86% | 24.566 SH | 08 Agosto 2026 | Giornaliero |
| PEXL · Pacer Funds Trust | 1,67% | 1.592 NS | 30 Aprile 2026 | N-PORT |
| FMCE · Northern Lights Fund Trust IV | 1,64% | 2.250 NS | 31 Maggio 2026 | N-PORT |
| FMCX · Northern Lights Fund Trust IV | 1,63% | 3.902 NS | 31 Maggio 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,53% | 1.276 NS | 31 Maggio 2026 | N-PORT |
| BKDV · BNY Mellon ETF Trust II | 1,43% | 41.397 NS | 30 Aprile 2026 | N-PORT |
| GKAT · Advisors Series Trust | 1,41% | 4.289 NS | 31 Marzo 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 1,32% | 1.154 NS | 30 Aprile 2026 | N-PORT |
| SNPV · DBX ETF Trust | 1,26% | 5.900 NS | 29 Maggio 2026 | N-PORT |
| ALRG · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 1,22% | 189 NS | 30 Aprile 2026 | N-PORT |
| LRGC · AB Active ETFs, Inc. | 1,20% | 30.508 NS | 31 Maggio 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 1,16% | 54.333 SH | 08 Agosto 2026 | Giornaliero |
| MFSG · MFS Active Exchange Traded Funds Tr… | 1,16% | 8.091 NS | 31 Maggio 2026 | N-PORT |
| RFFC · ALPS ETF Trust | 1,08% | 654 NS | 31 Maggio 2026 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 1,02% | 3.416 NS | 30 Aprile 2026 | N-PORT |
| FFND · Northern Lights Fund Trust II | 1,02% | 2.122 NS | 31 Maggio 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0,88% | 233.578 SH | 08 Agosto 2026 | Giornaliero |
| CAPE · DoubleLine ETF Trust | 0,86% | 4.580 NS | 31 Marzo 2026 | N-PORT |
| CRTC · DBX ETF Trust | 0,85% | 2.247 NS | 31 Maggio 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,84% | 15.398 NS | 30 Aprile 2026 | N-PORT |
| USXF · iShares Trust | 0,84% | 21.650 SH | 08 Agosto 2026 | Giornaliero |
| BSCQ · Invesco Exchange-Traded Self-Indexe… | 0,81% | 28.441.000 | 08 Agosto 2026 | Giornaliero |
| ZECP · Zacks Trust | 0,80% | 5.541 NS | 31 Maggio 2026 | N-PORT |
| IWX · iShares Trust | 0,79% | 54.993 SH | 08 Agosto 2026 | Giornaliero |
| TAX · EA Series Trust | 0,79% | 408 NS | 29 Maggio 2026 | N-PORT |
| BIGY · Tidal Trust II | 0,75% | 409 NS | 30 Aprile 2026 | N-PORT |
| OEI · Listed Funds Trust | 0,75% | 656 NS | 30 Aprile 2026 | N-PORT |
| IVE · iShares Trust | 0,72% | 615.615 SH | 08 Agosto 2026 | Giornaliero |
| FFLC · FIDELITY COVINGTON TRUST | 0,72% | 16.950 NS | 30 Aprile 2026 | N-PORT |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 0,71% | 1.284 NS | 30 Aprile 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,70% | 3.534.266 SH | 08 Agosto 2026 | Giornaliero |
| IUSV · iShares Trust | 0,68% | 322.866 SH | 08 Agosto 2026 | Giornaliero |